CALYPTE BIOMEDICAL CORP Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
CALYPTE BIOMEDICAL CORP reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$693.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-22.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2012-03-22
- CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2011-12-31 was -$256.00K.
- CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2011-09-30 was -$242.00K, a 102.31% decline year-over-year.
- CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2011-06-30 was -$296.00K.
- CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2011-03-31 was $101.00K.
- CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2011 was -$693.00K, a 107.61% decline from fiscal 2010.
- CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2010 was $9.11M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | -$498.00K derived: sum of 2 quarters · filed 2012-03-22 | -$794.00K derived: sum of 3 quarters · filed 2012-03-22 | -$693.00K 10-K · filed 2012-03-22 |
| 2011-09-30 | -$242.00K 10-Q · filed 2012-01-27 | -$538.00K derived: sum of 2 quarters · filed 2012-01-27 | -$437.00K 10-Q · filed 2012-01-27 | -$851.00K derived: sum of 4 quarters · filed 2012-03-22 |
| 2011-06-30 | -$296.00K 10-Q/A · filed 2011-11-30 | -$195.00K 10-Q/A · filed 2011-11-30 | -$609.00K derived: sum of 3 quarters · filed 2012-03-22 | $9.88M derived: sum of 4 quarters · filed 2012-03-22 |
| 2011-03-31 | $101.00K derived: 10-K 12 month − 3 quarters · filed 2012-03-22 | -$313.00K derived: sum of 2 quarters · filed 2012-03-22 | $10.18M derived: sum of 3 quarters · filed 2012-03-22 | $9.72M derived: sum of 4 quarters · filed 2012-03-22 |
| 2010-12-31 | -$414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $10.07M derived: sum of 2 quarters · filed 2012-03-22 | $9.62M derived: sum of 3 quarters · filed 2012-03-22 | $9.11M 10-K · filed 2012-03-22 |
| 2010-09-30 | $10.49M 10-Q · filed 2012-01-27 | $10.03M derived: sum of 2 quarters · filed 2012-01-27 | $9.52M 10-Q · filed 2012-01-27 | |
| 2010-06-30 | -$454.00K 10-Q/A · filed 2011-11-30 | -$966.00K 10-Q/A · filed 2011-11-30 |